380 results on '"Ansotegui, Ignacio"'
Search Results
2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
3. Time to ACT-UP: Update on precautionary allergen labelling (PAL)
4. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XI – Milk supplement/replacement formulas for infants and toddlers with CMA – Systematic review
5. Twenty-five years: The fexofenadine clinical experience
6. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – XVI - Nutritional management of cow's milk allergy
7. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XII – Recommendations on milk formula supplements with and without probiotics for infants and toddlers with CMA
8. Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee
9. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines update – X – Breastfeeding a baby with cow's milk allergy
10. Global disparities in availability of epinephrine auto-injectors
11. Refractory Anaphylaxis: A New Entity for Severe Anaphylaxis
12. Pollen respiratory allergy: Is it really seasonal?
13. Cutoff Values of MASK-air Patient-Reported Outcome Measures
14. WAO consensus on DEfinition of Food Allergy SEverity (DEFASE)
15. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis
16. Environmental contributions to the interactions of COVID-19 and asthma: A secondary publication and update
17. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guideline update – XIII – Oral immunotherapy for CMA – Systematic review
18. Digital tools in allergy and respiratory care
19. Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement
20. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19
21. World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guideline update – XIV – Recommendations on CMA immunotherapy
22. The international WAO/EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
23. Correction to: Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
24. Insights into urticaria in pediatric and adult populations and its management with fexofenadine hydrochloride
25. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19
26. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways
27. Food labeling issues for severe food allergic patients
28. Update on latex allergy: New insights into an old problem
29. The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations
30. The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management
31. Current situation of allergy education in Mexico and other parts of Latin America
32. Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review
33. A Proposal from the Montpellier World Health Organization Collaborating Centre for Better Management and Prevention of Anaphylaxis
34. COVID-19 vaccine-associated anaphylaxis: A statement of the World Allergy Organization Anaphylaxis Committee
35. Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic
36. Air pollution and indoor settings
37. Does Comorbid Food Allergy Affect Response to Omalizumab in Patients with Asthma?
38. Concurrent validity, cut‐offs and ability to change of patient‐reported outcome measures for rhinitis and asthma in MASK‐air®.
39. Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review.
40. Consensus on DEfinition of Food Allergy SEverity (DEFASE): Protocol for a systematic review
41. Current and Potential Biologic Drugs for the Treatment of Chronic Urticaria
42. World Allergy Organization Anaphylaxis Guidance 2020
43. Medical devices in allergy practice
44. Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD)
45. Beliefs and preferences regarding biological treatments for severe asthma
46. COVID-19, asthma, and biological therapies: What we need to know
47. The allergenic activity and clinical impact of individual IgE-antibody binding molecules from indoor allergen sources
48. Acute asthma management during SARS-CoV2-pandemic 2020
49. International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants: Impact of air pollution on patients with AR: Current knowledge and future strategies
50. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.